Russian vaccine Sputnik V and its significance for India discussed in Chennai

A webinar “Russian Vaccine Sputnik V and its significance for India” was held on October 17. It was organized by the Consulate General of Russia in South India, RCSC in Chennai and the Russian and Soviet Medical Graduates Association (RMGA).

In his address, Russian Consul General Mr. O.N. Avdeev stressed that "Russia has established itself as a clear leader in the vaccine research, having developed the safest and the most effective COVID vaccine".

"The Russian Vaccine Sputnik-V has been approved for phase II/III clinical trials in India," said Dr. Lalit Lakhwani, Head-Clinical Development at Dr. Reddy's Laboratory, a company that conducts clinical trials of the Russian vaccine in India.

Other speakers at the webinar were Dr. Ranga Reddy Burri, President of Infection Control Academy of India, Dr. D. Sureshkumar, MD, FNB (Inf. Disease), Consultant Infectious Disease, Apollo Hospitals Chennai, Dr. D.Rajivraj, Assistant Professor- Department of General Surgery, Sri Ramachandra Institute of Higher Education and Research, Consultant General Surgeon – Sri Ramachandra Medical Centre,  Dr. M. Arunachalam, MD, Founder President of the RMGA and Chairman, Arunvijaya Hospital, Chennai, Dr. Babu Ganesh, MD, President of the RMGA.

The webinar generated huge interest in the professional medical community. More than 120 people took part in the event: doctors, medical scientists and journalists. The video recording of the webinar on the RCSC's Facebook page has received more than 250 views on the first day.